Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.45 CHF | -0.25% | -2.29% | -5.38% |
04-26 | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
04-25 | BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 190M 208M 284M | Sales 2025 * | 101M 110M 150M | Capitalization | 2.22B 2.43B 3.32B |
---|---|---|---|---|---|
Net income 2024 * | 152M 166M 227M | Net income 2025 * | 72M 78.72M 108M | EV / Sales 2024 * | 13.2 x |
Net Debt 2024 * | 291M 318M 435M | Net Debt 2025 * | 324M 355M 485M | EV / Sales 2025 * | 25.3 x |
P/E ratio 2024 * |
14.6
x | P/E ratio 2025 * |
13.6
x | Employees | 10 |
Yield 2024 * |
5.81% | Yield 2025 * |
5.93% | Free-Float | 97.24% |
1 day | -0.25% | ||
1 week | -2.29% | ||
Current month | -11.20% | ||
1 month | -10.51% | ||
3 months | -8.28% | ||
6 months | +11.89% | ||
Current year | -5.38% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Koller
CIO | Chief Investment Officer | 54 | 03-12-31 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Meanwell
BRD | Director/Board Member | 67 | 03-12-31 |
Director/Board Member | 63 | 19-12-31 | |
Chairman | 63 | 19-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 40.45 | -0.25% | 51,176 |
24-04-25 | 40.55 | -2.17% | 59,657 |
24-04-24 | 41.45 | -0.36% | 57,148 |
24-04-23 | 41.6 | +0.97% | 113,601 |
24-04-22 | 41.2 | -0.48% | 63,519 |
Delayed Quote Swiss Exchange, April 26, 2024 at 11:31 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.38% | 2.43B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BION Stock